Publications (17) LOREA VALCARCEL JIMENEZ publications

2023

  1. FOXA2 controls the anti-oxidant response in FH-deficient cells

    Cell Reports, Vol. 42, Núm. 7

  2. Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism

    British Journal of Cancer, Vol. 129, Núm. 10, pp. 1546-1557

2022

  1. Angiocrine polyamine production regulates adiposity

    Nature Metabolism, Vol. 4, Núm. 3, pp. 327-343

  2. HIRA loss transforms FH-deficient cells

    Science Advances, Vol. 8, Núm. 42

2021

  1. Crosstalk between mechanotransduction and metabolism

    Nature Reviews Molecular Cell Biology, Vol. 22, Núm. 1, pp. 22-38

2020

  1. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  2. Targeting PML in triple negative breast cancer elicits growth suppression and senescence

    Cell Death and Differentiation, Vol. 27, Núm. 4, pp. 1186-1199

2019

  1. PGC1a suppresses prostate cancer cell invasion through ERRA transcriptional control

    Cancer Research, Vol. 79, Núm. 24, pp. 6153-6165

2018

  1. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

    Cell Death and Disease, Vol. 9, Núm. 10

  2. Low-dose statin treatment increases prostate cancer aggressiveness

    Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504

2017

  1. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

  2. Mitochondrial Metabolism: Yin and Yang for Tumor Progression

    Trends in Endocrinology and Metabolism, Vol. 28, Núm. 10, pp. 748-757

  3. New insights on prostate cancer progression

    Cell Cycle

2016

  1. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7

  2. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  3. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

    Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846

2015

  1. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30